IN THE UNITED STATES DISTRICT COURT FOR THE MIDDLE DISTRICT OF LOillSIANA JESSIE HOFFMAN * CIVIL ACTION No. 12-796 VERSUS * JUDGE JAMES BRADY BURL CAIN ET AL. * MAG. JUDGE STEPHEN RIEDLINGER **************************************************************************** RESPONSES ON BEHALF OF DEFENDANTS, BURL CAIN, WARDEN, JAMES LEBLANC, SECRETARY, AND ANGELA NORWOOD, WARDEN, TO PLAINTIFF CHRISTOPHER SEPULVADO'S SECOND SET OF REQUESTS FOR PRODUCTION NOW COME, Defendants, BURL CAIN, Warden, Louisiana State Penitentiary, JAMES LEBLANC, Secretary, Louisiana Department of Public Safety and Corrections ("DOC"), and ANGELA NORWOOD, Warden, Death Row, who, in regards to Plaintiff Christopher Sepulvado's Second Set of Requests for Production, submit the following responses: Please note that Defendants' Responses to Plaintiff's Second Set of Requests for Production are limited as follows: Defendants are not responding to Plaintiff's Second Set of Interrogatories on behalf of BOBBY JINDAL, Governor of Louisiana, or LOUISIANA DEPARTMENT OF PUBLIC SAFETY AND CORRECTIONS, as those parties were previously dismissed from this proceeding. Also, Defendants are not responding Plaintiff's Second Set of Requests for Production on behalf of any JOHN DOES, unknown executioners, as no such parties have been identified or joined as parties in this proceeding. Request for Production of Documents No.1: Any and all documents reflecting the inventory of supplies (including all purchase records) maintained by DOC for the purpose of administering lethal injections between October 1, 2013, and the present. 1 Response to Request for Production No.1: DOC has no records reflecting an inventory of pentobarbital that was being maintained for the purpose of administering lethal injections between October 1, 2013, and the present. DOC did have an expired inventory of pentobarbital during that time which was not being maintained for the purpose of administering lethal injections, and that inventory of pentobarbital was returned to the manufacturer. Please see attached documents reflecting DOC's purchase and possession of midazolam and hydromorphone. Defendants object to releasing any information which identifies or may be used to identify any company that was the manufacturer or source of the midazolam and/or the hydromorphone. The respective drug manufacturers are FDA-approved. That information has been redacted from this response and will be submitted to the Court under seal along with a Motion for Protective Order per FRCP 26(c). Request for Production of Documents No.2: Any and all documents related to any actions taken by the DOC regarding the stock of pentobarbital in possession ofthe DOC which expired as of"9/13", including but not limited to all documents of communications, including emails, with DOC employees, the federal Drug Enforcement Agency, or the Louisiana Board of Pharmacy regarding the maintenance or disposal of the pentobarbital. Response to Request for Production No.2: Louisiana State Penitentiary Pharmacy received a letter from the Louisiana Board of Pharmacy dated November 8, 2013. DOC returned the drug to the manufacturer who would have disposed of the pentobarbital. On January 14, 2014, the Louisiana Board of Pharmacy conducted an inspection of the Louisiana State Penitentiary Pharmacy. See documents attached. 2 Request for Production of Documents No.3: Any and all documents that describe any revisions or changes in the administration of lethal injection from October 1, 2013, to the present, including but not limited to any changes in the type or quantity of the lethal substance. Response to Request for Production No.3: The only documents that describe any revisions or changes in the administration of lethal injection from October 1, 2013, to the present were provided to Plaintiffs' counsel via e-mail on January 27,2014, which show revisions made that same day. Request for Production of Documents No. 4: Any and all documents reflecting any communications, including emails, with any other prisons or state officials regarding the administration of lethal injection, between October 1, 2013, and the present. Response to Request for Production No.4: Upon information and belief, Defendants received Ohio's execution protocol via fax from the Ohio DOC on January 27, 2014. There may be a fax coversheet of this transmittal in DOC's possession, which will be confirmed on Monday, February 3, 2014, and a supplementation to this response will be made at that time. Request for Production of Documents No.5: Any and all documents, including email communications, reflecting any attempt by the DOC to acquire any supplies related to lethal injection, including pharmaceutical agents, between September 1, 2013, and the present. 3 Response to Request for Production No.5: Please see documents submitted in response to the first set of requests for production. Defendants have no additional documents. Request for Production of Documents No.6: Any and all documents reflecting any communications, including emails, with any pharmacies regarding the procurement of any drug which may be used in lethal injection, between September 1, 2013, and the present. Response to Request for Production No.6: Please see documents submitted in response to the first set of requests for production. Please also see documents in response to Request for Production No. 1. Request for Production of Documents No.7: Any and all documents reflecting DOC's acquisition of the active pharmaceutical ingredient ("API") in any execution drug, including any and all attempts to acquire said API whether successful or not, and all documentation reflecting that a compounding pharmacy, or any individual(s) inside or outside of DOC, planned to prepare or actually prepared a drug from the API. Response to Request for Production No.7: Please see documents submitted in response to the first set of requests for production. Defendants have no additional documents. Request for Production of Documents No.8: All documentation reflecting efforts by the DOC to seek or obtain information regarding the Food & Drug Administration (FDA) approval status of any and all execution drugs, or API, and all correspondence concerning the FDA approval status of such drug(s). 4 Response to Request for Production No.8: Please see documents submitted in response to the first set of requests for production. Defendants have no additional documents. Request for Production of Documents No.9: All documentation of all training exercises related to lethal injection carried out since October 1, 2013. Response to Request for Production No.9: Please see documents submitted in response to the first set of requests for production. Please see additional documents attached. Request for Production of Tangible Things No. 10: Mr. Sepulvado requests, pursuant to Rule 34(a)(l)(B), for the Defendants to permit him or his representative to inspect, test, and sample the drug(s) that the DOC intends to use in its lethal injection protocol. Response to Production of Tangible Things No. 11: Objection. Plaintiff has no right to inspect, test, and/or sample the drugs that DOC intends to use in the lethal injection protocol. Further, Plaintiffs request is overbroad and does not designate a quantity that is to be tested, who is to conduct the testing, or the protocol to be utilized for the testing. 5 E. ctesho , La. R ll No. 7637, wade@scwllp.com James L. Hilburn, La. Bar Roll No. 20221, jamesh@scwllp.com Jeffrey K. Cody, La. Bar Roll No. 28536, jeffreyc@scwllp.com Jacqueline B. Wilson, La. Bar Roll No. 31055, jbw@scwllp.com SHOWS, CALI, & WALSH, L.L.P. 628 St. Louis Street (70802) P.O. Drawer 4425 Baton Rouge, Louisiana 70821 Telephone: (225) 346-1461 Facsimile: (225) 346-1467 CERTIFICATE OF SERVICE I certify that a copy of the foregoing was serve upon counsel for Plaintiffs via e-mail on I this 1st day of February, 2014. 6 5 ?Eu - \rn- hut-u rt w. . ?1 ., .. . .. •-L'-- .,__. ·Borrow, Loa;n and Sell :;-.:.:j,:\·,~ ·.:-r;;c:' ·· i\ § ·:-.. ·; :·y ·:::.> ·~ ·:·~.:><.t· . . . . Beglh Date! U1128f2!l14 '12:55-:43 ·, ·: :t·· .. ·i. Gen'eriit Natl'te., ··: y : Status tlafu O:'I/2812CH4· uo :aa:no· .End Oat~~ · 01[~8'12014 23 :59~S9 ·Paga i ·Of 1· -': . . . ' :• ._ : Phartt'la<:ist ::-: . ·r,;. :, :: f'aQ!Hty.'Name . ·.Sen 1DMGIML 50MG {tHY.OROMORPHONE _ . . • ·5-ML .VJAL. . = f . 2 -.J V11~~!201f 12:27:59 . t .20· !Sel! JFOREMAN, Gi..YN JSlAYN HUNT CORR.ECTfONAL CE . ' '/ •> l i ,, I .! ,. 5 ..lllJ -P-rii:iGllah!ltil Ft6t'lll.1 ~~ \W(I Plt!Jtlillibn P.t~ ill- Conlml;t ltllm ,.. ~ tlm1111 V =fllirne Vendor ~ dUJI;:l 11Wtl ()lass. 2 .,~~rl~llcl\s- 4"'Sclu;tlufe4-!5 l!"~~.~~~-» Promo%- CMS ncMS ·NON-MATCH NDCu h'trlrt Nov OG 2013 -·--- \1~06"Af'l LA 13Ct=IRD OF=" PHFIRl'tRCY -·-~-.,..---------~. Mary B. Labatul: Pnarmaclst-ln-Cba.rge Lovlslana State Penitentiary Pharmacy PO Sox 133 911 Warehouse Airport Rd Angola. l.A 70112 Re: Via Facsimile: (225) 655-27.26 Louisiana Pharrrnacy Pemtf1 No. PHY.001271-PEX &·ca~ No. 13--0445 Dear Ms. LabsM: Wa hava recalVed a complafnl aUeglng -your phalTf!Soy Is ln. possesslcn of al'i unknoWn quantity cl eleplred pentobarblt.at an-d further, that. your pharmacy intends to I.Ee thls exPired drug ptoduCt at SGme tlme 1n the ful.tu'e. : . · We caft your6nttcn to ltla !All!PJaa!i PhWi!J$Y·4W §oQir. ancl ~ s~ly LAC 46;LliJ.2S01.01 lNlllch pravi~~: . . · 'Expired drut/s Shall Dot be disptMsmi and shi!)}J be r6fi')(Wed from the phar-rnar.:y dmg lnventDtY." For me Soard: JJJ~ ~add'>J ;J~colm J BJ'CW$$~ Executlve Director RETURN AUTHORIZATioN! Ill ~111111111m 11111111111111111111111 •bRx . Please complete and send back original with your retum goods. · · Please copy for your records. ~GUARANTEED RETURNS W4 8 0 1 6 7 Please can 800-473~21!38 if the . whoiesa1er information !fisted Is DO NOT ch~nge 1this form. 100 Co~n Drive Holbrook. N¥11741-4306 H300473-2138 Customer Service • -;;-:;-::~;:o:i': .f..CPO{:Stlf/IJ/1 ··~.~!/}!&' ,, ...,. ·~-' ~ . }'1 5"'-lf' TVJ.J.I.c.A . ...,/!..A-c:--t· . . '. ···~ ·/J J l s-o . -·. . · · · · . . . . \.· .~ r-~~~ ~.. . : I • .. ~ •. A-AJt:oLA/ LA .tD1l7BuY!~ ROETEN Slllpp~r R.oo~r;e· 1----+- . . 7019022 009'48279 I Shipper R<)i:.l!pt 701902?. 00948262 E·MAIL ADDRESS: PROCESS PATS Nl:)CTPROCESSINO DATE THE WHOlESAlER USTED A.BOVE Will RECERVE YOUR CREOn MEMOS" IF THE WHOlESALER ASOVE IS INCORRECT YOlll MUST CALL 800..473-2138. · PO NOT USJE TH~S FORM IF YOU DO NOT USE. THE WHOlESAlER USTED. · ·----····-·--·--·---·-----------·····--·-·-·---..-·-----·· ·--- Et'xbsta?c?s 111113351215. 2. mama-(mmG?a'piy . ?z -- 'Edr?m?gq; @1041,_3 1-1 1-1-6910? (Mn?'tqmupimwm -. -.. -. i' 2 31"Dng Vin-1:: II 2.: 7 .1, Rmra?sgm? . . .. 11.2. . . Packagpm' PagkagaFi?-3325'xl'n . . .-. .-.., . -, - . . . lit/538 f, ?f . . . "mg-nemv??eid. .- 1 - .. :Ngme.mdIii". 1 . 71:3" '13'3721:2! 2.: J3, Hal. Lift: fwnv?fa?l?oxd?vmu: - 52:21Copy?: . JLoniiliana ~oarb .of ~barmatp 3388 Brentwood Drive, Baton Rouge, Lol,lisiana 70809-1700 www.phannacyJa.gov Telephone: 225-925-6496 Fax: 225-925-6499 E-Mail: fnfo@pharmacyJa.gov Ph.artn...aci.sMn'-€(J.8roe 19. PIC Name (last, First, Ml) ' \· 21.. License No. 120.Sex Labatut, Mary E. 13632 female· 122. Renewal Year 125.Batchelor, state, LA 70715 24. Address of Record 7717 La Hwy 418 ' Jules tlJay.. La:batUt. PST DouQias J. Patin. PST John Robichaux, PST Stacy Wilson, CPT Juanita L. Tavlor, CPT Kimberly Dixon, CPT Heather L. stutzman, CPT Carrie L Bordelon-Bibbee, CPT Shavla N. Howard; CPT i..i'~imse J Zip City, ; 27. I?fia.r:111:acv ~ff 2014 N:O. 13743 15473 15897 2841 7438 R~fi~wat; Yeal." 2014 2014 2014 13114 13/14 13!14 13/14 13/14 13/14 2317 11398 2614 10706 23. CE Compliant Yes [SJ NoD J25. Phone 225-492-2422 ~.e. ~oin.bf.IMt No 0 Exemot 0 Yes lR'!· Exempt 0 No 0 Yes 0 Exempt 0 No 0 Exempt [] Yes !81 No Yes )Zg Exempt 0 No 0 Exetnpt [] Yes 0 No Yes [gj 0 !Zl No Yes U No Yes Yes No Exemot 0. Exempt "0 EXempt fZl Compliance Yes No N/A 28. Credentials Displayed 29. Premises Clean/Orderly 3D. Adequate LightingNentilatlon 31. Adequate Refiigerationffemperature 32. Min. Rx Dept Size/Aisle Space 33. Sterile Compounding 34. Sink (LocatiOn & Temperature) 35. Required References 36. Securlty (Alarm) (Restricted Access) 37. Adequate Equipment 38. Meds. Misbranded, Non-Labeled, Exp. 5.2. Prior Inspection Date: 3/12113 39. Emergency Drug Cabinet 40. Electronic Record Keeping 41. Required Info. on CDS Rxs 42. CDS Invoices Retrievable/Dated 43. C-U Order FotmS 44. Perpetual C!i!CDS Annual Inventory Inventory Date (5/1113) 45. Policy & Procedure Manual 46. Phannaci$1 Register 47. Patient.Counseling 48. Intern!CPTffech Trainee 1.0. 0 ~ 0 0 D fgl 0 0 0 0 [gl 121 0 ~ !Z! 0 0 0 jgJ 0 l3l 0 0 0 0 0 0 D 0 0 53. Defieienctes!Non.compliance on Prior Inspection 27-CE,38,42,43 55. Comments: NOTE: A find(ng of satisfactory cofnpiiance is not indicative of a cteta'ifed ihspectioMnvesfigati'on and does not exclude the permitand/or staff from possible future violations of compliance. Addltlonal Petsonne[.: Chandricf... "' . _ _j_ ·- ! ·---,-.- 'ii' · - l - 0OM·----- 0 ·---w... 1---4----.. ,. _ _ _ _ _ , -- .. - · - - - · · · · ·--------····· ....... _______ r·· . . L . ,____i"ll ·---, ·~ ·1·--->>--.... .. ~-·- . -··· ........______________ ' ---------1·" \ I 'I ···----~- !·----+:·~-1 1· 1~ .... -~·- - - - . __ L_.